Home/Filings/4/0001104659-25-000888
4//SEC Filing

HARTOUNIAN HARTOUN 4

Accession 0001104659-25-000888

CIK 0001137883other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:31 PM ET

Size

5.7 KB

Accession

0001104659-25-000888

Insider Transaction Report

Form 4
Period: 2025-01-01
HARTOUNIAN HARTOUN
EVP, Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-01-01+50,00052,000 total
Footnotes (2)
  • [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
  • [F2]Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001214476

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:31 PM ET
Size
5.7 KB